PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies

Lin, KX; Istl, AC; Quan, D; Skaro, A; Tang, E; Zheng, XF

Zheng, XF (通讯作者)，Univ Western Ontario, Dept Pathol, London, ON N6A 5A5, Canada.;Zheng, XF (通讯作者)，Univ Western Ontario, Dept Surg, London, ON N6A 5A5, Canada.;Zheng, XF (通讯作者)，Univ Western Ontario, Dept Oncol, London, ON N6A 5A5, Canada.;Zheng, XF (通讯作者)，Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5A5, Canada.;Zheng, XF (通讯作者)，Lawson Hlth Res Inst, London, ON N6A 5A5, Canada.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023; ():

Abstract

Colorectal cancer (CRC) is the second most common cause of cancer mortality, with mismatch repair proficient (pMMR) and/or microsatellite stable (MSS)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索